The degree of complexity and crossover within MAPK signaling, and also shifts in pathways such as nuclear factor κB signaling, could also explain the modest effect of p38 inhibitors. The p38α ...

Despite significant advances in Parkinson's disease (PD) treatment, it remains incurable, with limited therapeutic options.